Aradigm Announces Receipt of Final FDA Minutes for the Type B Meetin...
02/22/19
Aradigm Announces Receipt of Final FDA Minutes for the Type B Meeting on January 25, 2019 BioSpace
HAYWARD, Calif.--(BUSINESS WIRE)-- Aradigm Corporation (Pink Market: ARDM) (“Aradigm” or the “Company”). At the Type B meeting, Aradigm presented the ...
[more]